p38 MAP kinase's emerging role as a tumor suppressor

被引:235
作者
Bulavin, DV [1 ]
Fornace, AJ
机构
[1] Inst Cellular & Mol Biol, Singapore 138673, Singapore
[2] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
来源
ADVANCES IN CANCER RESEARCH, VOL 92 | 2004年 / 92卷
关键词
D O I
10.1016/S0065-230X(04)92005-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The p38 proteins are an evolutionally conserved family of mitogen-activated protein kinases (MAPK). Recent studies have led to progress in our understanding the roles of p38 MAPK in regulation of tumorigenesis through key cellular growth-control mechanisms. Along with the previously well-characterized proapoptotic functions, new data highlight the critical contributions of p38 MAPK in the negative regulation of cell cycle progression. This review will focus on the ability of p38 MAPK to positively regulate several tumor suppressor (p53- and Rb-dependent) pathways and to attenuate oncogenic (Cdc25A and Cdc25B phosphatases) signals. The concept of p38 MAPK as a potential tumor suppressor will be developed. (c) 2004 Elsevier Inc.
引用
收藏
页码:95 / 118
页数:24
相关论文
共 111 条
  • [61] Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis
    Liao, Y
    Hung, MC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (19) : 6836 - 6848
  • [62] Three distinct signalling responses by murine fibroblasts to genotoxic stress
    Liu, ZG
    Baskaran, R
    LeaChou, ET
    Wood, LD
    Chen, Y
    Karin, M
    Wang, JYJ
    [J]. NATURE, 1996, 384 (6606) : 273 - 276
  • [63] Genes involved in senescence and immortalization
    Lundberg, AS
    Hahn, WG
    Gupta, P
    Weinberg, RA
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (06) : 705 - 709
  • [64] Rapid destruction of human Cdc25A in response to DNA damage
    Mailand, N
    Falck, J
    Lukas, C
    Syljuåsen, RG
    Welcker, M
    Bartek, J
    Lukas, L
    [J]. SCIENCE, 2000, 288 (5470) : 1425 - 1429
  • [65] PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation
    Margolis, SS
    Walsh, S
    Weiser, DC
    Yoshida, M
    Shenolikar, S
    Kornbluth, S
    [J]. EMBO JOURNAL, 2003, 22 (21) : 5734 - 5745
  • [66] Miki H, 1999, ANTICANCER RES, V19, P5283
  • [67] Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis
    Molinari, M
    Mercurio, C
    Dominguez, J
    Goubin, F
    Draetta, GF
    [J]. EMBO REPORTS, 2000, 1 (01) : 71 - 79
  • [68] Cdc42Hs, but not rad, inhibits serum-stimulated cell cycle progression at G(1)/S through a mechanism requiring p38/RK
    Molnar, A
    Theodoras, AM
    Zon, LI
    Kyriakis, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (20) : 13229 - 13235
  • [69] Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence
    Ohtani, N
    Zebedee, Z
    Huot, TJG
    Stinson, JA
    Sugimoto, M
    Ohashi, Y
    Sharrocks, AD
    Peters, G
    Hara, E
    [J]. NATURE, 2001, 409 (6823) : 1067 - 1070
  • [70] Pargellis Christopher, 2003, Curr Opin Investig Drugs, V4, P566